Aristotle Capital Boston, LLC Haemonetics Corp Transaction History

Aristotle Capital Boston, LLC

$1.95 Billion
Q1 2025

A detailed history of Aristotle Capital Boston, LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Aristotle Capital Boston, LLC holds 391,861 shares of HAE stock, worth $29.3 Million. This represents 1.28% of its overall portfolio holdings.

Number of Shares

391,861

Previous 380,617 2.95%

Holding current value

$29.3 Million

Previous $29.7 Million 16.21%

% of portfolio

1.28%

Previous 1.13%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$59.34 - $80.05 $667,218 - $900,082	11,244 Added 2.95%	391,861 $24.9 Million
Q4 2024 Feb 14, 2025	BUY	$71.16 - $93.38 $1.57 Million - $2.06 Million	22,011 Added 6.14%	380,617 $29.7 Million
Q3 2024 Nov 14, 2024	BUY	$72.45 - $91.58 $4 Million - $5.06 Million	55,232 Added 18.21%	358,606 $28.8 Million
Q2 2024 Aug 14, 2024	SELL	$81.24 - $97.37 $1.47 Million - $1.77 Million	-18,152 Reduced 5.65%	303,374 $25.1 Million
Q1 2024 May 15, 2024	BUY	$71.24 - $85.35 $1.16 Million - $1.39 Million	16,246 Added 5.32%	321,526 $27.4 Million
Q4 2023 Feb 14, 2024	SELL	$80.59 - $92.61 $514,647 - $591,407	-6,386 Reduced 2.05%	305,280 $26.1 Million
Q3 2023 Nov 14, 2023	SELL	$82.56 - $93.49 $109,804 - $124,341	-1,330 Reduced 0.42%	311,666 $27.9 Million
Q2 2023 Aug 14, 2023	BUY	$80.84 - $89.45 $583,018 - $645,113	7,212 Added 2.36%	312,996 $26.6 Million
Q1 2023 May 15, 2023	BUY	$72.75 - $90.6 $555,373 - $691,640	7,634 Added 2.56%	305,784 $25.3 Million
Q4 2022 Feb 14, 2023	SELL	$73.85 - $86.14 $570,195 - $665,086	-7,721 Reduced 2.52%	298,150 $23.4 Million
Q3 2022 Nov 14, 2022	SELL	$63.3 - $78.66 $1.65 Million - $2.06 Million	-26,140 Reduced 7.87%	305,871 $22.6 Million
Q2 2022 Aug 15, 2022	BUY	$49.27 - $66.08 $1.05 Million - $1.41 Million	21,396 Added 6.89%	332,011 $21.6 Million
Q1 2022 May 16, 2022	SELL	$43.77 - $63.22 $293,127 - $423,384	-6,697 Reduced 2.11%	310,615 $19.6 Million
Q4 2021 Feb 14, 2022	SELL	$49.55 - $74.59 $281,840 - $424,267	-5,688 Reduced 1.76%	317,312 $16.8 Million
Q3 2021 Nov 15, 2021	BUY	$57.6 - $70.59 $4.22 Million - $5.18 Million	73,322 Added 29.37%	323,000 $22.8 Million
Q2 2021 Aug 16, 2021	SELL	$51.81 - $118.56 $727,930 - $1.67 Million	-14,050 Reduced 5.33%	249,678 $16.6 Million
Q1 2021 May 17, 2021	BUY	$111.01 - $139.48 $3.58 Million - $4.5 Million	32,258 Added 13.94%	263,728 $29.3 Million
Q4 2020 Feb 22, 2021	BUY	$88.75 - $119.95 $140,580 - $190,000	1,584 Added 0.69%	231,470 $27.5 Million
Q4 2020 Feb 16, 2021	SELL	$88.75 - $119.95 $1.28 Million - $1.73 Million	-14,423 Reduced 5.9%	229,886 $27.3 Million
Q3 2020 Nov 16, 2020	BUY	$75.65 - $93.58 $18.5 Million - $22.9 Million	244,309 New	244,309 $21.3 Million

Others Institutions Holding HAE

# of Institutions

351

Shares Held

53.3M

Call Options Held

417K

Put Options Held

314K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.84B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aristotle Capital Boston, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aristotle Capital Boston, LLC with notifications on news.

Account

Aristotle Capital Boston, LLC Haemonetics Corp Transaction History